Professional Documents
Culture Documents
Borderline Ve Terapiler Tedavi
Borderline Ve Terapiler Tedavi
CITATION
Crotty, K., Viswanathan, M., Kennedy, S., Edlund, M. J., Ali, R., Siddiqui, M., Wines, R., Ratajczak, P., & Gartlehner, G.
(2023, October 30). Psychotherapies for the Treatment of Borderline Personality Disorder: A Systematic Review. Journal of
Consulting and Clinical Psychology. Advance online publication. https://dx.doi.org/10.1037/ccp0000833
Journal of Consulting and Clinical Psychology
© 2023 American Psychological Association
ISSN: 0022-006X https://doi.org/10.1037/ccp0000833
Objective: Borderline personality disorder (BPD) is the most common personality disorder, affecting 1.8%
This document is copyrighted by the American Psychological Association or one of its allied publishers.
of the general population, 10% of psychiatric outpatients, and 15%–25% of psychiatric inpatients. Practice
guidelines recommend psychotherapies as first-line treatments. However, psychotherapies commonly used
for the treatment of BPD are numerous, and little is known about the comparative effectiveness of each
individual psychotherapy versus treatment as usual (TAU) or other psychotherapies. To systematically
assess the comparative effectiveness of commonly used psychotherapies versus TAU or versus other
psychotherapies for BPD treatment. Method: We conducted systematic literature searches in MEDLINE,
EMBASE, the Cochrane Library, and APA PsycINFO up to July 14, 2022, and searched reference lists of
pertinent articles and reviews. Inclusion criteria were (a) patients 13 years or older with a diagnosis of BPD,
(b) treatment with commonly used psychotherapies, (c) comparison with TAU or another psychotherapy,
(d) assessment of relevant BPD-related health outcomes, and (e) randomized or nonrandomized trials or
controlled observational studies. Two investigators independently screened abstracts and full-text articles
and graded the certainty of evidence using the Grading of Recommendations Assessment, Development,
and Evaluation approach. Results: We found 25 psychotherapy studies meeting inclusion criteria with data
on 2,545 participants. Seventeen studies compared nine psychotherapies with TAU and nine studies
compared eight psychotherapies with another psychotherapy for the treatment of BPD. Overall, both TAU
and included psychotherapies were effective in treating the severity and symptoms of BPD. Moderate
certainty of evidence suggests that systems training for emotional predictability and problem solving is
more effective than TAU for the treatment of BPD; low certainty of evidence suggests that dialectical
behavior therapy, schema therapy, transference-focused psychotherapy, acceptance and commitment
therapy, manual-assisted cognitive therapy, and cognitive behavioral therapy are more effective than TAU
for treating BPD. We were unable to draw conclusions from head-to-head comparisons of psychotherapies,
which were limited to single studies with very low to low certainty of evidence. Conclusions: All commonly
used psychotherapies improve BPD severity, symptoms, and functioning. Our assessment found no strong
evidence suggesting that any one psychotherapy is more beneficial than another.
Keywords: borderline personality disorder, psychotherapies, dialectical behavior therapy, self-harm, suicide
continued
1
2 CROTTY ET AL.
about 85% reaching diagnostic remission within 10 years after In patients with borderline personality disorder, what is the comparative
diagnosis (Gunderson et al., 2011)—specific symptoms, such as fear effectiveness, and risk of harms of psychotherapies?
of abandonment, impulsivity, intense anger, and an unstable self-
Figure 1 presents the analytic framework for our key questions.
image can persist over a lifetime. Individuals with BPD also
commonly suffer from other mental disorders, including depression,
anxiety, posttraumatic stress disorder, substance use disorders, Literature Searches
and eating disorders. They frequently face social stigma, have poor
We built our searches on an earlier search strategy developed for
social and occupational outcomes (Niesten et al., 2016), and have a
APA (see Supplemental Material) with modifications to make
substantial risk for suicide death (Paris, 2019). Individuals with searches more specific. To ensure optimal recall, we ensured that
BPD are frequent users of general primary care and the societal the revised search strategy detected all studies that met the inclusion
costs of BPD are substantial; the annual direct health care costs and criteria of the original search. We searched MEDLINE, EMBASE,
indirect costs (i.e., lost productivity) are more than 16 times higher the Cochrane Library, and APA PsycInfo from January 1, 2018, to
among patients with BPD compared with matched controls without July 14, 2022, using a variety of terms, medical subject headings,
BPD (Hastrup et al., 2019). and major headings limited to English language and human-only
Clinical practice guidelines recommend psychotherapies as first- studies (see Supplemental Material). To minimize retrieval bias, we
line treatment for BPD (American Psychiatric Association [APA], manually searched reference lists of landmark studies and
2001; National Collaborating Centre for Mental Health, 2018; background articles for relevant citations that electronic searches
Simonsen et al., 2019) with a particular emphasis on dialectical might have missed.
behavior therapy (DBT), a structured modular and hierarchical
treatment consisting of a combination of individual psychotherapy,
group skills training, and telephone coaching, guided by a therapist Criteria for Inclusion/Exclusion of Studies in the Review
consultation team (Linehan, 1993). However, the extent to which Our population of interest were patients 13 years of age or older
guidelines are evidence-based varies: A recent study found that over with a diagnosis of BPD. Included psychotherapies were those that we
half of clinical practice guidelines are not based on systematic found to be most commonly studied in the literature and determined as
reviews, which could lead to potentially misleading and untrust- eligible for inclusion by experts at APA. The following psychothera-
worthy results (Lunny et al., 2021). pies used to treat BPD were included: DBT, mentalization-based
To strengthen evidence-based clinical practice and on behalf treatment (MBT), systems training for emotional predictability and
of the APA, we conducted a systematic review of the comparative problem solving (STEPPS), dynamic deconstructive psychotherapy,
effectiveness of pharmacological and nonpharmacological treat- transference-focused psychotherapy, schema therapy, abandonment
ment approaches for BPD patients. The purpose of the work was to therapy, acceptance and commitment therapy (ACT), manual-assisted
provide an update of APA’s clinical practice guideline on treatments cognitive therapy (MACT), supportive therapy, cognitive behavioral
for BPD. Results for the comparative effectiveness of pharmaco- therapy (CBT), and generalized psychiatric treatment. Eligible active
logical treatments for the treatment of BPD were published comparators included treatment as usual (TAU) and other
previously (Gartlehner et al., 2021). The current article presents the psychotherapies (see Supplemental Material, for a list of all eligible
results for the comparative effectiveness of psychotherapy treat- psychotherapy comparators). We defined TAU as interventions
ments for BPD patients. that were described as TAU, had a flexible approach, and did not
analysis, and investigation and an equal role in writing–review and editing. analysis, investigation, and writing–original draft. Gerald Gartlehner played
Rania Ali played a supporting role in data curation, formal analysis, a lead role in conceptualization, funding acquisition, investigation,
investigation, and writing–original draft. Mariam Siddiqui played a methodology, project administration, and writing–review and editing and
supporting role in data curation, formal analysis, investigation, and an equal role in data curation, formal analysis, and writing–original draft.
writing–original draft. Roberta Wines played a supporting role in data Correspondence concerning this article should be addressed to Karen
curation, formal analysis, investigation, methodology, and writing–original Crotty, RTI International, Research Triangle Park, 3040 East Cornwallis
draft. Piotr Ratajczak played a supporting role in data curation, formal Road, NC 27709-2194, United States. Email: kcrotty@rti.org
PSYCHOTHERAPIES FOR BORDERLINE PERSONALITY DISORDER 3
Figure 1
Analytic Framework
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
Pyschotherapies
Individuals ≥ 13 years Intermediate Outcomes: Health Outcomes:
old with diagnosed Legal system Improvement of symptoms
borderline personality involvement Self-harm behaviors
disorder Changes in core Clinical global impression
illness features Mortality
Specific subgroups Service use Patient reported outcomes
This document is copyrighted by the American Psychological Association or one of its allied publishers.
Note. See the online article for the color version of this figure.
adhere to a manualized or prespecified regimen. Outcomes of studies. For RCTs, we used the Cochrane Risk of Bias Tool 2.0 (J.
interest included the improvement of BPD-specific symptoms (e.g., A. C. Sterne et al., 2019). We assigned a “high risk of bias” rating to
self-harm, suicide attempts, depression, anxiety, impulsiveness, studies that had very serious limitations in design or conduct that
emotional regulation, dissociation experience, hopelessness), global might invalidate findings. We resolved disagreements between
clinical assessment, functioning, and adverse events. In addition to the two reviewers by discussion and consensus or by consulting the
randomized controlled trials (RCTs), we included non-RCTs with a third team member.
comparison arm. Non-RCTs often study the effectiveness of
interventions on populations excluded from RCTs and are better Data Synthesis
suited to assessing harms, particularly rare and long-term harms which
are often too small or too short to be reliably assessed by RCTs. The We summarized included studies in narrative form and in
Supplemental Material provides a detailed presentation of inclusion summary tables. To determine whether quantitative (i.e., meta-
and exclusion criteria. analysis) or qualitative analyses were appropriate, we followed
established guidance to assess the clinical and methodological
heterogeneity of the studies under consideration (Gartlehner et al.,
Literature Review, Data Abstraction, and
2012). We found that studies were not similar due to heterogeneity
Data Management in treatment methods, insufficient numbers of similar studies, or
We used DistillerSR to screen the literature (DistillerSR, insufficiency or variation in outcome reporting. We therefore
Evidence Partners, Ottawa, Canada). Two reviewers independently avoided the pooling of clinically distinct populations and instead
reviewed all titles, abstracts, and full-text articles and resolved synthesized the data narratively.
discrepancies by consensus or by involving a third, senior reviewer.
A list of studies excluded (with reasons) at the full-text level can Grading the Certainty of Evidence for Major
be found in the Supplemental Material. For data extraction, we Comparisons and Outcomes
designed, pilot tested, and used a structured data form in DistillerSR
to ensure consistency of data extraction. One reviewer extracted We graded the certainty of evidence of relevant outcomes
data and the second team member verified extracted study data for based on current Grading of Recommendations Assessment,
accuracy and completeness. Development, and Evaluation guidance (Balshem et al., 2011).
Two reviewers assessed each domain for each selected outcome
and resolved differences by consensus discussion. We documented
Assessment of Risk of Bias of Individual Studies
all decisions regarding up- or down-grading the certainty of
To assess the risk of bias of studies, two independent reviewers evidence to ensure transparency. We used GradePro (https://grade
used the risk of bias in nonrandomized studies of interventions pro.org) to rate the certainty of evidence and develop a summary of
(ROBINS-I; J. A. Sterne et al., 2016) for nonrandomized controlled findings tables.
4 CROTTY ET AL.
Role of the Funding Source included, DBT was included as a study arm in 12 studies, MBT in
five studies, STEPPS, schema therapy, and transference-focused
This review was funded by APA. The APA Clinical Guidelines
psychotherapy were each study arms in four studies, and manualized
Committee assisted in the development of key questions, study
supportive therapy was a study arm in three studies. All other
inclusion criteria, and outcome measures of interest but was not
included psychotherapies were investigated in a single study.
involved in data collection, analysis, or article preparation.
We rated just one study as having a low risk of bias (Carter
et al., 2010), 10 studies in 12 publications as some concerns for
Results bias (Bateman et al., 2021; Bateman & Fonagy, 2009; Bos et al.,
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
Results of Literature Search and Literature Screening 2010; Carlyle et al., 2020; Davidson et al., 2006; Farrell
et al., 2009; Hilden et al., 2021; McMain et al., 2017; Morton
Of 3,754 unique records screened, 25 studies (20 RCTs, three et al., 2012; van den Bosch et al., 2005; Verheul et al., 2003;
nonrandomized trials, one prospective cohort study, and one Weinberg et al., 2006) and 14 studies in 18 publications as high
retrospective cohort study) in 31 publications met inclusion criteria. risk of bias (Arntz et al., 2022; Barnicot & Crawford, 2019; Beck
Figure 2 presents the literature search and selection process. et al., 2020; Blum et al., 2008; Bohus et al., 2004; Clarkin et al.,
This document is copyrighted by the American Psychological Association or one of its allied publishers.
Of the included studies, 17 (in 18 publications) compared nine 2007; Doering et al., 2010; Feigenbaum et al., 2012; Giesen-Bloo
commonly used psychotherapies with TAU (Arntz et al., 2022; Beck et al., 2006; González-González et al., 2021; Gregory &
et al., 2020; Blum et al., 2008; Bohus et al., 2004; Bos et al., 2010; Sachdeva, 2016; Guillén Botella et al., 2021; Jørgensen et al.,
Carter et al., 2010; Davidson et al., 2006; Doering et al., 2010;
2013; Links et al., 2013; McMain et al., 2009, 2012; Sachdeva et
Farrell et al., 2009; Feigenbaum et al., 2012; González-González
al., 2013; Spinhoven et al., 2007). Primary reasons for high risk-
et al., 2021; Gregory & Sachdeva, 2016; Hilden et al., 2021;
of-bias ratings were a lack of intention to treat analysis and high
McMain et al., 2017; Morton et al., 2012; van den Bosch et al., 2005;
rates of attrition (see Supplemental Material).
Verheul et al., 2003; Weinberg et al., 2006); nine studies (in 14
Overall, included trials provided data on 2,545 participants.
publications) compared eight commonly used psychotherapies
Studies predominantly enrolled female participants: females
with another psychotherapy for the treatment of BPD (Barnicot &
accounted for all participants in six studies and for more than
Crawford, 2019; Bateman et al., 2021; Bateman & Fonagy, 2009;
80% of participants in 21 of 25 studies. More than half of studies
Carlyle et al., 2020; Clarkin et al., 2007; Giesen-Bloo et al., 2006;
failed to report race or ethnicity. When reported, most participants
Gregory & Sachdeva, 2016; Guillén Botella et al., 2021; Jørgensen
were White. Study durations ranged from 12 weeks to 3 years,
et al., 2013; Links et al., 2013; McMain et al., 2009, 2012; Sachdeva
with the exception of one study that had six sessions over 6–8
et al., 2013; Spinhoven et al., 2007). Among the psychotherapies
weeks (Weinberg et al., 2006). In general, studies excluded
patients with psychiatric comorbidities, such as schizophrenia,
Figure 2 major depressive disorder, alcohol or substance use disorder, or
PRISMA Flowchart bipolar disorder.
Table 1 summarizes the main study characteristics of studies that
Records idenfied through databases: compare commonly used psychotherapies for the treatment of
(n = 3,754) BPD with TAU or with another commonly used psychotherapy.
More detailed information on study characteristics and treatment
effects can be found in the Supplemental Material. Certainty-of-
evidence ratings are also presented with the Supplemental Tables
Records screened: S1–S18.
( n = 3,754) In the following sections, we first present evidence for the
comparative effectiveness of commonly used psychotherapies
versus TAU. Next, we present evidence for the comparative
Records excluded:
( n = 3,566)
effectiveness of commonly used psychotherapies versus another
psychotherapy. Finally, we present evidence related to harms. For
assessing comparative effectiveness, we summarize findings, (when
Records assessed for reported) for three outcome domains: (a) severity of BPD, (b)
eligibility: # of full-text arcles excluded: 157
(n = 188) Ineligible populaon (n = 16) severity of symptoms associated with BPD, (c) and general
Ineligible intervenon (n = 89) psychiatric symptoms and functioning. Effect measures are
Ineligible comparator (n = 1) generally presented as points on clinical assessment scales at
Ineligible outcome (n = 10)
Ineligible ming (n = 3)
endpoint. Characteristics of commonly used scales for the clinical
Study design (n = 26) assessment of patients with BPD can be found in the Supplemental
Duplicate or superseded (n = 3) Material.
Non-English full text ( n =1)
Ineligible country (n = 5)
25 studies Not primary research (n = 3)
reported in 31 publicaons Commonly Used Psychotherapies Versus
Treatment as Usual
Note. PRISMA = preferred reporting items for systematic reviews and Table 2 presents an evidence map with findings for commonly
meta-analyses. used psychotherapies versus TAU.
This document is copyrighted by the American Psychological Association or one of its allied publishers.
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
Table 1
Study Characteristics of Commonly Used Psychotherapies Versus TAU or Versus Another Commonly Used Psychotherapy for the Treatment of BPD
Table 1 (continued) 6
Author (year) Number of participants
Study design Interventions Study population Risk of
Funding Duration Setting, country Sample demographics Primary outcome bias
Carter et al. (2010) N = 76 Females; 18–65 years of age; DSM-IV Mage: 25 Deliberate self-harm Low
Design: RCT DBT: Combined weekly individual psychotherapy criteria for BPD; history of multiple % female: 100 and hospitalizations
NR sessions, weekly skills training groups, and episodes of deliberate self-harm with at % race/ethnicity: NR because of self-
weekly supervision and consultation meetings for least three self-reported episodes in harm at 6 months
the therapists. preceding 12 months
TAU (waitlist): A range of individualized service Outpatient, single center, Australia
provisions and professional mental health care.
12 months
Davidson et al. (2006) N = 106 Males and females; 18–65 years of age; met Mage: 32 Suicidal acts, Some
RCT CBT: Average of 27 sessions of CBT over 12 criteria for at least five items of the BPD % female: 84 psychiatric concerns
Other, foundation months in addition to TAU; each session lasted 1 using the DSM-IV Axis II personality % race/ethnicity: hospitalization,
hr. disorders; received either inpatient White: 100 accident, and
TAU: Case management provided by hospital and psychiatric services or an assessment at emergency
primary and community care services. accident and emergency services attendance at 24
24 months Outpatient, multicenter, United Kingdom months
Doering et al. (2010) N = 104 Females; 18–45 years of age; diagnosis of Mage: 28 Suicide attempts, High
RCT TFP: Modified psychodynamic therapy consisted of BPD by DSM-IV criteria % female: 100 dropout from
Other, Austrian bank two 50-min sessions delivered every week by Outpatient, multicenter, Austria and % race/ethnicity: NR therapy at 12
experienced clinical psychologists or medical Germany months
doctors, along with medications as needed for 1
year of treatment.
TAU: Individualized standard care from community
psychiatrists.
12 months
Farrell et al. (2009) Females; 18 and 65 years of age; diagnosis NR Some
CROTTY ET AL.
N = 32 Mage: 36
RCT ST: 30 weekly 1.5-hr group sessions. Treatment of BPD using DIB-R and Borderline % female: 100 concerns
Government, NIMH focused on emotional awareness, Syndrome Index; individual % race/ethnicity: NR
psychoeducation, distress management, and psychotherapy of at least 6 months
schema-focused change work. duration and stable
TAU: Weekly individual psychotherapy in the Outpatient, multicenter, United States
community.
8 months
Follow-up: 6 months
Feigenbaum et al. N = 42 Males and females; 18–65 years of age; Mage: 35 CORE-OM at 12 High
(2012) DBT: Combined weekly individual psychotherapy DSM-IV criteria for cluster B personality % female: 73 months
RCT sessions, weekly skills training groups, and disorder % race/ethnicity: NR
Government, C&IHA, weekly supervision and consultation meetings for Outpatient, single center, United Kingdom
NTRHA the therapists.
TAU (waitlist): A range of individualized service
provisions and professional mental health care.
12 months
(table continues)
This document is copyrighted by the American Psychological Association or one of its allied publishers.
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
Table 1 (continued)
20 weeks to enrollment
Follow-up: 32 weeks Outpatient, single center, Canada
Morton et al. (2012) N = 41 Males and females; 18–55 years of age; ≥4 Mage: 35 BEST at 13 weeks Some
RCT ACT: Weekly group sessions that included DSM-IV criteria of BPD; registered client % female: 93 concerns
NR performing mindfulness exercises, doing of a public sector adult mental health % race/ethnicity: NR
emotions skills training, focusing on awareness of service
one’s values, and identifying choice points for Outpatient, multicenter, Australia
action.
TAU: Case management provided by public mental
health services.
13 weeks
(table continues)
7
This document is copyrighted by the American Psychological Association or one of its allied publishers.
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
Table 1 (continued) 8
Author (year) Number of participants
Study design Interventions Study population Risk of
Funding Duration Setting, country Sample demographics Primary outcome bias
Verheul et al. (2003) N = 64 Females; 18–70 years of age, diagnosed Mage: 35 NR Some
van den Bosch et al. DBT: Combined weekly individual psychotherapy with BPD; referred by psychologist or % female: 100 concerns
(2005) sessions, weekly skills training groups, and psychiatrist willing to sign an agreement % race/ethnicity: NR
RCT weekly supervision and consultation meetings for to commit to delivering 12 months of
Dutch Health Insurance the therapists. TAU
Company TAU (waitlist): A range of individualized service Outpatient, various settings, the Netherlands
provisions and professional mental health care.
52 weeks
Weinberg et al. (2006) N = 30 Females; 18–40 years of age; met DSM-IV Mage: 28 NR Some
RCT MACT: Six sessions, over 6–8 weeks, incorporating and DIB-R criteria for BPD; history of % female: 100 concerns
Other, foundation elements of DBT, CBT, and bibliotherapy, repetitive deliberate self-harm with at least % race/ethnicity:
modified to focus on deliberate self-harm; each one episode during the month before White: 93
session was structured around a chapter of a enrollment Nonwhite: 7
booklet, covering functional analysis of episodes Outpatient, single center, United States
of parasuicide (defined as deliberate self-harm or
suicide attempts), emotion regulation strategies,
problem-solving strategies, management of
negative thinking, management of substance use,
and relapse prevention strategies.
TAU: Standard of care not further specified.
Six sessions (duration NR)
Nonrandomized clinical training, telephone skills coaching, and team outpatient DBT or MBT % race/ethnicity:
trial consultation. Outpatient, multicenter, United Kingdom White: 64
Government, NIH MBT: Weekly or fortnightly individual therapy and Black and minority: 36
weekly group therapy along with a short-term 10-
week group program offering psychoeducation
and support aimed at helping patients get a better
understanding of their problems and suggestions
for better ways of dealing with them.
12 months
Bateman and Fonagy N = 134 Males and females; 18–65 years of age; Mage: 31 Suicide, self-injury, Some
(2009) MBT: 18-month manualized weekly combined diagnosis of BPD using DSM-IV criteria; % female: 80 and hospitalizations concerns
Bateman et al. (2021) individual and group psychotherapy. suicide attempt or episode of life- % race/ethnicity: at 18 months
RCT Supportive therapy: SCM involving individual and threatening self-harm within last 6 months White: 72
Other, foundation group sessions, therapy based on supportive Outpatient, single center, United Kingdom Black: 18
approach with case management, advocacy Other: 10
support, and problem-oriented psychotherapeutic
interventions.
Both groups also received crisis contact and crisis
plans, pharmacotherapy, general psychiatric
review, and written information about treatment.
18 months
(table continues)
This document is copyrighted by the American Psychological Association or one of its allied publishers.
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
Table 1 (continued)
Nonrandomized clinical skills training, telephone skills coaching, and Outpatient, multicenter, Spain % race/ethnicity:
trial team consultation. Caucasian: 100
NR STEPPS: Includes group therapy, a reinforcement
team, telephone consultations with relatives,
consultations with other professionals, and
weekly clinician meetings.
6 months
(table continues)
9
This document is copyrighted by the American Psychological Association or one of its allied publishers.
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
Table 1 (continued) 10
Author (year) Number of participants
Study design Interventions Study population Risk of
Funding Duration Setting, country Sample demographics Primary outcome bias
Jørgensen et al. (2013) N = 111 randomized, n = 85 treated Males and females; age 21 and older; met Mage: 30 GAF at 24 months High
RCT MBT: Weekly individual therapy, weekly group DSM-IV criteria for BPD as assessed by % female: 96
NR therapy, monthly group psychoeducational SCID-II; GAF score above 34 % race/ethnicity: NR
program. Outpatient, single center, Denmark
Supportive therapy: Biweekly group therapy,
monthly group psychoeducational program.
Both groups also participated in a
psychoeducational program with group-based
psychoeducation once a month for 6 months and
were offered medical treatment in accordance
with APA recommendation.
24 months
Links et al. (2013) N = 180 Males and females; 18–60 years of age; Mage: 30 Suicidal episodes, High
McMain et al. (2009) DBT: Weekly individual therapy and group skills DSM-IV criteria for BPD; at least two % female: 86 nonsuicidal self-
McMain et al. (2012) training, weekly telephone coaching with explicit episodes of suicidal or nonsuicidal self- % race/ethnicity: NR injury at 12 months
RCT focus on self-harm and suicidal behavior, and injurious episodes in the past 5 years, at
Government weekly therapist team consultation. least one of which was in the 3 months
General psychiatric management: Weekly preceding enrollment
individual therapy that was expanded away from Both inpatient and outpatient, Canada
focusing on self-harm and suicidal behaviors and
included medication management; general
psychiatric therapy also included mandated
therapist supervision weekly meetings.
12 months
CROTTY ET AL.
Note. We used the Cochrane Risk of Bias Tool 2.0 for RCTs, and the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) for non-RCTs. Use of the term “some concerns for risk of
bias” for non-RCTs equates to “moderate risk of bias” on the ROBINS-I tool (see Supplemental Material). ACT = acceptance and commitment therapy; APsaA = American Psychoanalytic Association;
BDCFT = Bradford District Care National Health Service Foundation Trust; BDSI-IV = Borderline Syndrome Index–IV; BEST = borderline evaluation of severity over time; BPD = borderline
personality disorder; BPD-40 = Borderline Personality Disorder Checklist–40; BPDRF = Borderline Personality Disorder Research Foundation; BPDSI = Borderline Personality Disorder Severity Index;
BSL-23 = Borderline Symptom List–23; C&IHA = Camden and Islington Health Authority; CBT = cognitive behavioral therapy; CORE-OM = Clinical Outcomes in Routine Evaluation–Outcome
Measure; DBT = dialectical behavior therapy; DDP = dynamic deconstructive psychotherapy; DFG = German Research Foundation; DIB-R = Diagnostic Interview for Borderlines–Revised; DSM =
Diagnostic and Statistical Manual of Mental Disorders; GAF = global assessment of functioning; MACT = manual-assisted cognitive therapy; MBT = mentalization-based treatment; N = sample size;
NIH = National Institutes of Health; NIMH = National Institute of Mental Health; NR = not reported; NSSI = nonsuicidal self-injury; NTRHA = North Thames Regional Health Authority; RCT =
randomized controlled trial; SCID = Structured Clinical Interview for DSM-IV; SCL-90 = Symptom Checklist–90; SCM = structured clinical management; SLaM = South London and Maudsley
National Health Service Foundation Trust; ST = schema therapy; STEPPS = systems training for emotional predictability and problem solving; TAU = treatment as usual; TFP = transference-focused
psychotherapy; APA = American Psychiatric Association.
a
Gregory and Sachdeva (2016) is a three-arm trial with a total N = 68.
PSYCHOTHERAPIES FOR BORDERLINE PERSONALITY DISORDER 11
Table 2
Evidence Map With Findings for Commonly Used Psychotherapies Versus TAU
Number (K) of Studies
Range of Study Durations
Commonly used Outcomes
psychotherapies Number (n) of Participants by Outcome
versus treatment Certainty of Evidence
as usual Incidence Withdrawa
Incidence
Global Impression and of Serious l Due to
Severity of BPD Severity of Symptoms Associated with BPD of Adverse
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
LOW for similar effects LOW for similar effects LOW for similar effects
STEPPS vs. TAU K=3 K=1 K=2 K=1 K=1 No evidence No evidence No evidence
(Blum et al., 2008; 20 weeks–24 months 20 weeks–12 months 20 weeks– 20 weeks 12 months
Bos et al., 2010; 12 months
González-González Severity of BPD
et al., 2021) n = 362 Depression, impulsiveness Self-harm General Functioni Quality of
n = 165 attempts, suicide psychopatho ng n = 124 life
attempts logy n = 244 N = 79
n = 165
MODERATE for LOW for greater effect with STEPPS LOW for similar MODERAT LOW for Moderate
greater effect with effects E for greater greater for greater
STEPPS effect with effect effect
STEPPS with with
STEPPS STEPPS
VERY LOW for greater VERY LOW for greater effect with VERY LOW for VERY LOW for greater effect with
effect with DDP DDP similar effects DDP
LOW for inconsistent LOW for greater effect with LOW for similar effect LOW for greater effect MODERAT
findings ST with ST E for greater
effect with
ST
(table continues)
12 CROTTY ET AL.
Table 2 (continued)
Number (K) of Studies
Range of Study Durations
Commonly used Outcomes
Number (n) of Participants by Outcome
psychotherapies
Certainty of Evidence
versus treatment
Incidence Withdrawa
as usual Incidence
Global Impression and of Serious l Due to
Severity of BPD Severity of Symptoms Associated with BPD of Adverse
Functioning Adverse Adverse
Events
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
Events Events
Acceptance and K=1 K=1
Commitment n = 41 n = 41 No evidence No evidence No evidence No evidence
Therapy (ACT) vs. 13 weeks 13 weeks
TAU (Morton et al.,
2012) Severity of BPD Anxiety, depression, emotion regulation, hopelessness
LOW for greater effect LOW for greater effect with ACT
with ACT
This document is copyrighted by the American Psychological Association or one of its allied publishers.
Note. K = number of studies; n = number of participants; TAU = treatment as usual; BPD = borderline personality disorder; STEPPS = systems training
for emotional predictability and problem solving. See the online article for the color version of this table.
Dialectical Behavior Therapy Versus Treatment as Usual treated with DBT and TAU after 12 months (Gregory &
Sachdeva, 2016).
Six studies (seven publications), four RCTs (Carter et al., 2010;
Feigenbaum et al., 2012; McMain et al., 2017; van den Bosch et al.,
2005; Verheul et al., 2003), a nonrandomized trial (Bohus et al., Severity of Symptoms Associated With Borderline
2004), and a retrospective cohort study (Gregory & Sachdeva, 2016) Personality Disorder
evaluated the efficacy of DBT compared with TAU. Overall, these
studies provided data on 357 participants. We rated three studies as Two RCTs reported fewer suicide attempts by participants
having a high risk of bias (Bohus et al., 2004; Feigenbaum et al., assigned to the DBT group than by participants assigned to TAU
2012; Gregory & Sachdeva, 2016), two as some concerns for risk of reaching statistical significance in just one (8% vs. 6%, p < .04;
bias (McMain et al., 2017; van den Bosch et al., 2005; Verheul et al., McMain et al., 2017; van den Bosch et al., 2005; Verheul et al.,
2003), and one as low risk of bias (Carter et al., 2010). Follow-up 2003). In contrast, two other studies (one RCT; Feigenbaum et al.,
durations ranged from 4 to 12 months. All except one study 2012) and one cohort study (Gregory & Sachdeva, 2016) reported
(Gregory & Sachdeva, 2016) employed a waitlist design where no significant differences in suicide attempts between treatment
participants in the TAU groups were offered DBT at the end of the groups.
study. Overall, we found low strength of evidence favoring DBT All studies reported on self-harm, defined variously as deliberate
over TAU for the treatment of one or more BPD-related outcomes. self-harm, self-injury, and self-mutilation. Most trials showed
greater reductions in self-harm in the DBT group than in the TAU
group. The only study rated as low risk of bias also reported
Severity of Borderline Personality Disorder numerically fewer episodes of self-harm, but no statistically
significant differences in the number or proportion of self-harm
In one study (N = 84), participants receiving brief DBT achieved episodes between those receiving TAU and those receiving DBT
significantly greater reductions on the Borderline Symptom List–23 (Carter et al., 2010). Two trials (N = 114) reported a reduction in
compared with participants in the TAU group at the end of the self-mutilating behaviors (35% vs. 57%; p = .003 and 62% vs. 31%,
intervention (5 months; −22.6 vs. −10.3, p < .01) but not at the 8- p = .039) among participants receiving DBT compared with those
month follow-up (McMain et al., 2017). A retrospective cohort receiving TAU (Bohus et al., 2004; Verheul et al., 2003).
study (N = 41) reported no significant differences on the borderline Two studies reported on dissociative experiences, aggression,
evaluation of severity over time (BEST) scale between participants anger, depression, and impulsiveness (see Table 2; Bohus et al.,
PSYCHOTHERAPIES FOR BORDERLINE PERSONALITY DISORDER 13
2004; Feigenbaum et al., 2012; McMain et al., 2017). However, Severity of Symptoms Associated With Borderline
findings were graded as very low certainty of evidence, preventing Personality Disorder
us from drawing any conclusions from the data.
One study reported significant improvement in impulsiveness
(72.7 vs. 76.8, p = .004) and depression (22.0 vs. 25.8, p = .03) for
participants in the STEPPS group when compared with TAU at 5
Global Impression and Functioning
months (Blum et al., 2008). The same study reported no significant
In one study, more participants in the brief DBT group than in the differences in the number of suicide attempts or self-harm acts at 12
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
with TAU (Bohus et al., 2004). and quality of life at the end of treatment with no difference between
treatments on some measures over the longer term. At their primary
endpoints, both RCTs reported significant improvement on the
MBT Versus Treatment as Usual Symptom Checklist–90 (SCL-90) at 5 months, 12.5 versus 14.1
(data scaled), p = .03 (Blum et al., 2008), and at 12 months, 199.2
MBT is a psychodynamic treatment rooted in attachment and
versus 222.7, p = .001 (Bos et al., 2010). One study reported
cognitive theory. Treatment consists of weekly combined
significant improvement for the STEPPS group when compared
individual and group psychotherapy, focusing on the mentalizing
with TAU at 5 months in clinical global impressions (CGI) severity
strengths and failures associated with the affective, impulsive, and
(4.4 vs. 4.7, p < .001) and CGI improvement (2.7 vs. 3.8, p < .001)
interpersonal symptoms of BPD (Bateman et al., 2021). One RCT ratings, but found no significant differences between 5 months and
(N = 112), rated as high risk of bias, evaluated the efficacy of MBT 12 months on the SCL-90 or CGI severity or improvement ratings
compared with TAU in 14–17-year-old participants (Beck et al., (Blum et al., 2008).
2020). This was the only study of adolescents with BPD meeting Regarding functioning, one study reported significant differences
inclusion criteria. After 12 months of treatment, the study reported favoring the STEPPS group at 5 months (50.5 vs. 43.5, p < .001 on
no significant differences between groups in severity of BPD, the Global Assessment Scale) but no significant differences between
severity of symptoms, and global impression and functioning (see 5 and 12 months (Blum et al., 2008). The same study reported no
Supplemental Material). significant differences in social adjustment (measured by the Social
Adjustment Scale at 5 months and between 5 and 12 months).
One study rated reported significant improvement in the World
Systems Training for Emotional Predictability and
Health Organization Quality of Life Brief scale for the STEPPS
Problem Solving Versus Treatment as Usual
group when compared with TAU at 12 months (12.6 vs. 11.3 p =
STEPPS is a group treatment that combines cognitive behavior .006; Bos et al., 2010).
elements and skills training with a systems component for
individuals with whom a patient regularly interacts (Blum et al., Dynamic Deconstructive Psychotherapy Versus
2008). Two RCTs—one rated as some concerns for risk of bias (Bos Treatment as Usual
et al., 2010) and the other as high risk of bias (Blum et al., 2008)—
and a high risk-of-bias prospective cohort study (González- Dynamic deconstructive psychotherapy combines elements of
González et al., 2021) evaluated the efficacy of STEPPS compared translational neuroscience, object relations theory, and deconstruc-
with TAU. Together, the studies provided data on 362 participants. tion philosophy (Gregory & Remen, 2008). A retrospective cohort
Overall, across multiple outcomes, moderate-to-low certainty of study of 44 participants rated high risk of bias (Gregory & Sachdeva,
evidence favored STEPPS over TAU for the treatment of BPD. 2016) evaluated the efficacy of dynamic deconstructive psycho-
therapy compared with TAU. At 12 months’ follow-up, outcomes
related to severity of BPD, severity of symptoms, and functioning
Severity of Borderline Personality Disorder tended to favor dynamic deconstructive psychotherapy (Table 2 and
in the Supplemental Material). However, results were graded as very
Both trials reported significant improvements in the severity of low certainty of evidence, meaning that we have very low
BPD, 9.8 versus 13.4, p = .001 on the Zanarini Rating Scale for BPD confidence that the findings reflect the true effect. Therefore, we
(Blum et al., 2008) and 78.2 versus 88.6, p = .001 on the Borderline cannot draw conclusions from the data.
Personality Disorder Checklist–40 (Bos et al., 2010), at the primary
endpoint (5 and 12 months, respectively). Similarly, using the BEST
Schema Therapy Versus Treatment as Usual
scale, the cohort study reported significantly improved BPD severity
at 2 years for participants receiving STEPPS compared with those Schema therapy combines emotional awareness training,
receiving TAU (47.3 vs. 28.8, p < .01; González-González psychoeducation, distress management training, and schema change
et al., 2021). work (Farrell et al., 2009). Three RCTs (N = 569) evaluated the
14 CROTTY ET AL.
efficacy of schema therapy (Arntz et al., 2022; Farrell et al., 2009; for participants receiving schema therapy in addition to TAU
Hilden et al., 2021). One compared schema therapy plus TAU to compared to those receiving TAU alone (Farrell et al., 2009).
TAU alone (Farrell et al., 2009). The other two compared schema
therapy alone to some form of TAU (Arntz et al., 2022; Hilden et al., Transference-Focused Psychotherapy Versus
2021). Two were rated as some concerns for risk of bias (Farrell et
Treatment as Usual
al., 2009; Hilden et al., 2021), and one was rated as high risk of bias
(Arntz et al., 2022). Transference-focused psychotherapy is a modified psychody-
namic psychotherapy for people with BPD (Doering et al., 2010).
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
One RCT (N = 104), rated as high risk of bias, evaluated the efficacy
Severity of Borderline Personality Disorder of transference-focused psychotherapy compared with TAU
Two RCTs reported on the severity of BPD with mixed findings (Doering et al., 2010).
(Arntz et al., 2022; Hilden et al., 2021). Both studies reported
differences from baseline rather than endpoint scores. One study Severity of Borderline Personality Disorder
(N = 42), rated some concerns for risk of bias, found no statistically
This document is copyrighted by the American Psychological Association or one of its allied publishers.
significant difference between participants receiving schema Transference-focused psychotherapy was superior to TAU for the
therapy and those receiving TAU in Borderline Symptom List– number of Diagnostic and Statistical Manual of Mental Disorders,
23 decline at 20 weeks (6.95 in the schema therapy group vs. 12.55 Fourth Edition (DSM-IV) diagnostic criteria (on average for BPD)
in the TAU group, p = .34; Hilden et al., 2021). In the other trial, and for the proportion of participants having fewer than five DSM-IV
rated high risk of bias, at 3 years’ follow-up, participants receiving borderline criteria after 1 year (42.3% vs. 15.4%; p = .002; Doering
schema therapy (either predominantly group or combined individual et al., 2010).
and group therapy) reported significantly greater reductions from
baseline in BPD severity index total scores compared with Severity of Symptoms Associated With Borderline
participants receiving TAU with a medium-to-large effect size Personality Disorder
(standardized mean difference [SMD] 0.73; p = .001; Arntz et al.,
2022). Similarly, compared with TAU, treatment with schema At 12 months’ follow-up, the study found greater improvements
therapy resulted in greater reductions in borderline personality in the severity of BPD among participants receiving transference-
disorder checklist scores at 3 years’ follow-up (SMD, 0.33; p = .04; focused psychotherapy compared with TAU—significantly more
Arntz et al., 2022). participants in the transference-focused psychotherapy group met
fewer than five DSM-IV criteria for BPD at 12 months (42.3% vs.
15.4%; p = .002).
Severity of Symptoms Associated With Borderline The study also measured suicide attempts, depression, and
Personality Disorder anxiety, but these outcomes were graded as very low certainty
of evidence, which prevented us from drawing meaningful
Two RCTs reported on the severity of symptoms associated with conclusions.
BPD, with mixed findings (Farrell et al., 2009; Hilden et al., 2021).
One study, rated some concerns for risk of bias, reported no
significant difference among participants receiving schema therapy Global Impression and Functioning
and those receiving TAU in mean overall anxiety severity and Transference-focused psychotherapy was significantly superior
impairment scale scores and in depression scores at 20 weeks to TAU for global assessment of functioning scores (58.62 vs.
(Hilden et al., 2021). Another study, also rated some concerns for 56.06; p = .002) but not for the Brief Symptom Inventory.
risk of bias, reported significant improvements (lower scores) on the
borderline symptom index at 14 months for participants receiving
schema therapy compared to those receiving TAU (15.75 vs. 33.08, Acceptance and Commitment Therapy Versus
respectively, at endpoint, p < .001; Farrell et al., 2009). Treatment as Usual
Acceptance and commitment therapy is an action-oriented
Global Impression and Functioning approach to psychotherapy that stems from traditional behavior
therapy and CBT. ACT applies mindfulness and acceptance
Two RCTs reported on functioning and general psychopathology processes, and commitment and behavior change processes, to
(Arntz et al., 2022; Farrell et al., 2009) and one reported on quality the creation of psychological flexibility (Hayes et al., 1999). One
of life (Arntz et al., 2022). All found treatment with schema therapy RCT (N = 41) rated as some concerns for risk of bias, evaluated the
more effective than TAU. In one study, rated high risk of bias, at 36 efficacy of ACT in addition to TAU compared with TAU alone
months’ follow-up schema therapy was significantly superior to (Morton et al., 2012).
TAU for global assessment of functioning scores (SMD, 0.49; p =
.008), brief symptom inventory scores (SMD, 0.42; p = .005), and Severity of Borderline Personality Disorder
on the World Health Organization Quality-of-Life scale (SMD,
0.26; p = .01; Arntz et al., 2022). Similarly, another study, rated as After 13 weeks of treatment, the study reported significantly
some concerns for risk of bias, reported significantly better global greater improvements from baseline on the BEST scale for
assessment of functioning scores (66.19 vs. 48.24, p < .001) and participants in the ACT plus TAU group compared with TAU
Symptom Checklist–90 scores (0.96 vs. 1.93, p < .001) at 14 months alone (−11.8 vs. −2.4; p = .028; Morton et al., 2012).
PSYCHOTHERAPIES FOR BORDERLINE PERSONALITY DISORDER 15
Depression Anxiety Stress Scale (−3.66 vs. +2.08; p = .025). Commonly Used Psychotherapies
Changes on the subscales for depression and stress of the Depression
Anxiety Stress Scale were also greater for the ACT group but did not Table 3 provides an overview of the findings of the evidence
achieve statistical significance (Morton et al., 2012). comparing commonly used psychotherapies with other
psychotherapies.
This document is copyrighted by the American Psychological Association or one of its allied publishers.
Manual-Assisted Cognitive Therapy Versus DBT Versus MBT, STEPPS, Dynamic Deconstructive
Treatment as Usual Psychotherapy, Transference-Focused Psychotherapy,
Manual-assisted cognitive therapy incorporates elements of DBT, and Supportive Therapy
CBT, and bibliotherapy (Weinberg et al., 2006). One some concerns
As outlined in Table 3 and in the Supplemental Material, one
for risk-of-bias RCT (N = 30) evaluated the efficacy of MACT,
nonrandomized clinical trial (N = 90) rated high risk of bias,
compared with TAU (Weinberg et al., 2006).
compared DBT with MBT for BPD (Barnicot & Crawford, 2019).
Another nonrandomized clinical trial (N = 72) rated high risk of
bias, compared DBT with STEPPS (Guillén Botella et al., 2021). A
Severity of Symptoms Associated With Borderline three-armed retrospective cohort study (reported in two publica-
Personality Disorder tions) rated high risk of bias, compared DBT (N = 25) with dynamic
deconstructive psychotherapy (N = 27) and TAU in 68 patients with
The study reported significant reductions in the frequency (1.98
BPD (Gregory & Sachdeva, 2016; Sachdeva et al., 2013). A three-
vs. 6.69, p < .001), and severity (0.51 vs. 1.01, p < .001) of
armed RCT (N = 62) rated as high risk of bias compared DBT with
deliberate self-harm for participants in the MACT group when
transference-focused psychotherapy and with supportive therapy
compared with TAU after 6 months of treatment. The authors
(Clarkin et al., 2007). These studies reported on multiple outcomes,
recorded the use of the Parasuicide History Interview to identify the
including BPD severity, symptoms, and global functioning (Table 3
frequency or severity of deliberate self-harm but did not specify the
and in the Supplemental Material). However, for each comparison,
range of the scale for assessing severity.
the certainty of evidence was graded as very low, which prevented
meaningful conclusions. Therefore, there is currently insufficient
Cognitive Behavioral Therapy Versus evidence to determine the comparative effectiveness of DBT versus
these other psychotherapies.
Treatment as Usual
The borderline personality disorder study of cognitive therapy Dialectical Behavior Therapy Versus Manualized
(BOSCOT; N = 106) randomized trial rated as some concerns for
General Psychiatric Management for Borderline
risk of bias, evaluated the efficacy of CBT in addition to TAU
Personality Disorder
compared with TAU alone (Davidson et al., 2006).
One RCT, described in three publications and rated high risk of
bias, compared DBT with well-specified manualized general
Severity of Symptoms Associated With Borderline psychiatric management in 180 patients with BPD (Links et al.,
Personality Disorder 2013; McMain et al., 2009, 2012).
Table 3
Evidence Map With Findings for Commonly Used Psychotherapies Versus Another Commonly Used Psychotherapy
Number (K) of Studies
Number (n) of Participants
Commonly used Range of Study Durations
psychotherapies Outcomes
versus other Certainty of Evidence
commonly used Incidence Withdrawa
Incidence
psychotherapies Global Impression and of Serious l Due to
Severity of BPD Severity of Symptoms Associated with BPD of Adverse
Functioning Adverse Adverse
Events
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
Events Events
DBT vs. MBT K=1 K=1 No evidence No evidence No No evidence
(Barnicot & n = 90 n = 90 evidence
Crawford, 2019) 12 months 12 months
Severity of BPD Dissociative experiences, emotional dysregulation, self-harm
incidents
VERY LOW for similar VERY LOW for similar effects
effects
DBT vs. K=1 K=1 K=1 No evidence No No evidence
manualized n = 180 n = 180 n = 180 evidence
general psychiatric 12 months 12 months 12 months
This document is copyrighted by the American Psychological Association or one of its allied publishers.
management for
BPD (Links et al., Severity of BPD Depression Nonsuicidal self- Interpersonal functioning, symptom
2013; McMain et injuries, suicidal distress
al., 2012; McMain episodes
et al., 2009) LOW for similar effects LOW for similar effects at 12 months LOW for similar LOW for similar effects
effects
LOW for greater effect with general
psychiatric management at 36 months
DBT vs. STEPPS K=1 K=1 K=1 No evidence No No evidence
(Guillén Botella et n = 72 n = 72 n = 72 evidence
al., 2021) 6 months 6 months 6 months
Severity of BPD Anxiety, depression, dissociation experiences, suicide risk Quality of life
VERY LOW for greater VERY LOW for similar effects VERY LOW for similar effects
effect with DBT
Similar effects Favors first psychotherapy Favors second psychotherapy Inconsistent findings
Note. K = number of studies; n = number of participants; BPD = borderline personality disorder; DBT = dialectical behavior therapy; MBT =
mentalization-based treatmen; STEPPS = systems training for emotional predictability and problem solvingt; DDP = dynamic deconstructive
psychotherapy; TFP = transference-focused psychotherapy. See the online article for the color version of this table.
PSYCHOTHERAPIES FOR BORDERLINE PERSONALITY DISORDER 17
severity, including the number of suicidal episodes and the number evidence from these same two studies prevented us from drawing
of nonsuicidal self-injuries. With respect to depression, there was no meaningful conclusions related to general psychopathology and
significant difference between groups in Beck Depression Inventory interpersonal functioning (Bateman & Fonagy, 2009; Jørgensen
scores at the end of the 12-month treatment phase. However, at 36 et al., 2013).
months (24-month posttreatment), mean Beck Depression Inventory
scores were significantly lower among patients in the general
psychiatric management group than in the DBT group (17.4 vs. Transference-Focused Psychotherapy Versus
12.7; p = .004; McMain et al., 2012). Supportive Therapy and Schema-Focused Therapy
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
supportive treatment. Treatment-related harms were very poorly meta-analysis did not meet criteria based on established guidance
reported, with no obvious differences across psychotherapies. (Gartlehner et al., 2012) and could be misleading.
DBT was the most studied psychotherapy for the treatment of Because we did not combine results, our findings are less
BPD; it was included as a study arm in 12 of the 25 studies meeting definitive than other recent systematic reviews in terms of the
inclusion criteria. Low strength of evidence suggests that DBT is effectiveness of psychotherapy versus TAU but are very similar to
more effective than TAU in reducing symptoms associated with other systematic reviews in that we found no significant differences
BPD and improving functioning, but mixed findings suggest that across various psychotherapy treatments. A 2020 Cochrane meta-
TAU may be as effective as DBT in improving the severity of BPD. analysis of findings from 16 different psychotherapies in RCTs
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
Due to very low certainty of evidence, we were unable to draw published through March 2019 found moderately good quality
conclusions from studies comparing DBT with MBT, transference- evidence that psychotherapy reduces BPD symptom severity
focused psychotherapy, supportive therapy, STEPSS, and dynamic compared to TAU; SMD: −0.52, 95% confidence interval (CI)
deconstructive psychotherapy. Overall, despite its dominance and [−0.70, −0.33]; 22 trials (Storebø et al., 2020). The review also
popularity as a first-line psychotherapy treatment for BPD, we did found low-quality evidence that psychotherapy may be more
not find DBT to be superior to other psychotherapies. effective than TAU at reducing self-harm and suicide-related
This document is copyrighted by the American Psychological Association or one of its allied publishers.
MBT is arguably the second most popular line of psychotherapy outcomes and may be more effective than TAU at improving
for the treatment of BPD. However, we found low strength of psychosocial functioning (Storebø et al., 2020). Similar to our
evidence from just one study of 112 adolescent participants, which findings, the review found no clear differences between the various
suggests no difference between MBT and TAU for severity of BPD, psychotherapies for the treatment of BPD. A 2018 meta-analysis
severity of symptoms, or global impression and functioning (Beck combined findings from studies that compared DBT, MBT, or TFP
et al., 2020). In terms of comparative effectiveness, the evidence was to TAU or community treatment by experts and also found
inconsistent and generally of very low certainty, preventing moderate-quality evidence that these psychotherapies are effective
meaningful conclusions. Overall, the evidence does not support in reducing overall BPD severity (SMD: −0.59; 95% CI [−0.90,
recommending MBT over TAU for the treatment of BPD in −0.28]; Oud et al., 2018). The analysis found no differences for
adolescents and does not support the use of MBT over other almost any outcomes when comparing the selected psychotherapies
psychotherapies. to other protocolized psychological treatments, including general
Low-to-moderate certainty of evidence suggests that STEPPS is psychiatric management, structured clinical management, client-
more effective than TAU for improving BPD severity, severity of centered therapy, and supportive psychotherapy (Oud et al., 2018).
A 2017 systematic review and meta-analysis of adults with BPD
symptoms associated with BPD, and global impression and
found that, compared with TAU, DBT and psychodynamic
functioning. There is insufficient evidence comparing STEPPS to
approaches were effective in improving BPD symptoms and self-
other psychotherapies for the treatment of BPD.
harm and suicide outcomes; like the other reviews, it found no
Low-to-moderate certainty of evidence suggests that schema
difference between types of psychotherapies (Cristea et al., 2017).
therapy is more effective than TAU for improving BPD symptoms,
There are several notable limitations to this systematic review.
global functioning, and quality of life. However, findings were
We limited study populations to those diagnosed with DSM-IV or
inconsistent for the effectiveness of schema therapy compared with
later, thereby excluding some early trials. We did not require
TAU for treating the severity of BPD, and low strength of evidence
included studies to have a registered published protocol—
suggests that TAU is as effective as schema therapy for treating
consequently, selective reporting bias is a possibility. Discerning
depression and anxiety among patients with BPD. There is
which comparators to categorize as TAU was sometimes challeng-
insufficient evidence comparing schema therapy to other psy-
ing. We defined TAU as interventions that were explicitly described
chotherapies for the treatment of BPD. as TAU, had a flexible approach, and did not adhere to a manualized
Multiple factors, including overlapping treatment components or prespecified regimen. However, TAU varied broadly across
across the various psychotherapies, variations in the provision of studies, introducing substantial heterogeneity and making synthesis
TAU, variations in treatment protocols across studies, and and comparisons challenging. Similarly, psychotherapy compo-
significant challenges in studying patients with BPD, contribute nents, intensity, and duration often varied across studies, which
to the lack of robust evidence for the comparative effectiveness of introduced further heterogeneity. Added to differences in BPD
psychotherapies to treat BPD. Characteristics of the disorder make it symptomatology among participants, as well as differences in
particularly difficult to retain participants in trials. In addition, therapist type and expertise, these likely explain some of the
treatment implementation, level of therapist expertise, and patient observed inconsistencies. In addition, the small number of trials for
symptoms can vary tremendously across studies, making cross- each psychotherapy lowered the overall strength of evidence,
study comparisons difficult and open to misinterpretation if studies particularly for examining head-to-head studies comparing a
are inappropriately combined. commonly used psychotherapy to another psychotherapy. A wide
Since this review was focused on the comparative effectiveness of range of outcome measures with varying scales were employed
individual psychotherapies, we did not combine findings across across studies to measure the severity of BPD, BPD-specific
psychotherapies for a meta-analysis of “any psychotherapy” versus symptoms, global clinical assessment, and functioning, which
TAU. Where sufficient information was available (e.g., for DBT, further complicated and limited comparisons.
STEPPS, and schema therapy), we did consider meta-analysis for In clinical practice, patients with BPD are often treated with
each psychotherapy versus TAU, but given substantial heterogene- medication alone or in conjunction with psychotherapy. In a
ity across studies in terms of the patient populations studied, previous systematic review we conducted, which analyzed the
outcomes measured, and intervention fidelity, we determined that comparative effectiveness of pharmacological treatments for BPD,
PSYCHOTHERAPIES FOR BORDERLINE PERSONALITY DISORDER 19
we found that there is insufficient evidence to support the efficacy of Bateman, A., Constantinou, M. P., Fonagy, P., & Holzer, S. (2021). Eight-
pharmacotherapies alone in reducing the severity of BPD year prospective follow-up of mentalization-based treatment versus
(Gartlehner et al., 2021). Therefore, considering these findings, structured clinical management for people with borderline personality
psychotherapies should be a more frequently utilized option for disorder. Personality Disorders, 12(4), 291–299. https://doi.org/10.1037/
treating BPD. Our findings also suggest that generalized psy- per0000422
Bateman, A., & Fonagy, P. (2009). Randomized controlled trial of outpatient
chotherapies may be as effective as intensive specialized BPD
mentalization-based treatment versus structured clinical management for
treatments that require expert training. While this finding needs to be
borderline personality disorder. The American Journal of Psychiatry,
confirmed with additional higher quality evidence it provides new
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
The strength of evidence for the general effectiveness and Blum, N., St. John, D., Pfohl, B., Stuart, S., McCormick, B., Allen, J., Arndt,
S., & Black, D. W. (2008). Systems training for emotional predictability and
comparative effectiveness of commonly used psychotherapies for
problem solving (STEPPS) for outpatients with borderline personality
the treatment of BPD is mostly low to very low. The findings from
disorder: A randomized controlled trial and 1-year follow-up. The American
this systematic review suggest that all commonly used psychothera- Journal of Psychiatry, 165(4), 468–478. https://doi.org/10.1176/appi.ajp
pies and TAU improve BPD severity, symptoms, and functioning, .2007.07071079
and there is no strong evidence suggesting that any one commonly Bohus, M., Haaf, B., Simms, T., Limberger, M. F., Schmahl, C., Unckel, C.,
used psychotherapy is more beneficial than another. In addition, Lieb, K., & Linehan, M. M. (2004). Effectiveness of inpatient dialectical
very little is known about psychotherapy-related harms. To improve behavioral therapy for borderline personality disorder: A controlled trial.
the strength of evidence, future research in this area should focus on Behaviour Research and Therapy, 42(5), 487–499. https://doi.org/10
standardizing intervention components and treatment protocols, .1016/S0005-7967(03)00174-8
improving intervention fidelity, and selecting common outcome Bos, E. H., van Wel, E. B., Appelo, M. T., & Verbraak, M. J. (2010). A
measures to measure BPD severity and related symptoms. In randomized controlled trial of a Dutch version of systems training for
emotional predictability and problem solving for borderline personality
addition, to confirm some of the key findings found in this
disorder. Journal of Nervous and Mental Disease, 198(4), 299–304.
systematic review, future research should focus on determining
https://doi.org/10.1097/NMD.0b013e3181d619cf
whether specialized therapies for reducing the severity of BPD Carlyle, D., Green, R., Inder, M., Porter, R., Crowe, M., Mulder, R., &
including DBT and MBT are any more effective than TAU or Frampton, C. (2020). A randomized-controlled trial of mentalization-
treatment with more generalized psychotherapies. Future research based treatment compared with structured case management for borderline
should also focus on head-to-head comparisons across those personality disorder in a mainstream public health service. Frontiers in
psychotherapies that showed effectiveness over TAU including Psychiatry, 11, Article 561916. https://doi.org/10.3389/fpsyt.2020
DBT, STEPPS, schema therapy, transference-focused psychother- .561916
apy, ACT, MACT, and CBT. Carter, G. L., Willcox, C. H., Lewin, T. J., Conrad, A. M., & Bendit, N.
(2010). Hunter DBT project: Randomized controlled trial of dialectical
behaviour therapy in women with borderline personality disorder. The
References Australian and New Zealand Journal of Psychiatry, 44(2), 162–173.
American Psychiatric Association. (2001). Practice guideline for the https://doi.org/10.3109/00048670903393621
treatment of patients with borderline personality disorder. The Clarkin, J. F., Levy, K. N., Lenzenweger, M. F., & Kernberg, O. F. (2007).
American Journal of Psychiatry, 158(10, Suppl.), 1–52. https://www Evaluating three treatments for borderline personality disorder: A
.appi.org/american_psychiatric_association_practice_guideline_for_the_ multiwave study. The American Journal of Psychiatry, 164(6), 922–
treatment_of_patients_with_borderline_personality_disorder 928. https://doi.org/10.1176/ajp.2007.164.6.922
Arntz, A., Jacob, G. A., Lee, C. W., Brand-de Wilde, O. M., Fassbinder, E., Cristea, I. A., Gentili, C., Cotet, C. D., Palomba, D., Barbui, C., & Cuijpers,
Harper, R. P., Lavender, A., Lockwood, G., Malogiannis, I. A., Ruths, P. (2017). Efficacy of psychotherapies for borderline personality disorder:
F. A., Schweiger, U., Shaw, I. A., Zarbock, G., & Farrell, J. M. (2022). A systematic review and meta-analysis. JAMA Psychiatry, 74(4), 319–
Effectiveness of predominantly group schema therapy and combined 328. https://doi.org/10.1001/jamapsychiatry.2016.4287
individual and group schema therapy for borderline personality disorder: Davidson, K., Norrie, J., Tyrer, P., Gumley, A., Tata, P., Murray, H., &
A randomized clinical trial. JAMA Psychiatry, 79(4), 287–299. https:// Palmer, S. (2006). The effectiveness of cognitive behavior therapy for
doi.org/10.1001/jamapsychiatry.2022.0010 borderline personality disorder: Results from the borderline personality
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., disorder study of cognitive therapy (BOSCOT) trial. Journal of
Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., Norris, S., & Guyatt, Personality Disorders, 20(5), 450–465. https://doi.org/10.1521/pedi
G. H. (2011). GRADE guidelines: 3. Rating the quality of evidence. .2006.20.5.450
Journal of Clinical Epidemiology, 64(4), 401–406. https://doi.org/10 Doering, S., Hörz, S., Rentrop, M., Fischer-Kern, M., Schuster, P., Benecke,
.1016/j.jclinepi.2010.07.015 C., Buchheim, A., Martius, P., & Buchheim, P. (2010). Transference-
Barnicot, K., & Crawford, M. (2019). Dialectical behaviour therapy v. focused psychotherapy v. treatment by community psychotherapists for
mentalisation-based therapy for borderline personality disorder. borderline personality disorder: Randomised controlled trial. The British
Psychological Medicine, 49(12), 2060–2068. https://doi.org/10.1017/ Journal of Psychiatry, 196(5), 389–395. https://doi.org/10.1192/bjp.bp
S0033291718002878 .109.070177
20 CROTTY ET AL.
Farrell, J. M., Shaw, I. A., & Webber, M. A. (2009). A schema-focused borderline personality disorder symptoms: A randomized pilot study.
approach to group psychotherapy for outpatients with borderline Nordic Journal of Psychiatry, 75(3), 176–185. https://doi.org/10.1080/
personality disorder: A randomized controlled trial. Journal of Behavior 08039488.2020.1826050
Therapy and Experimental Psychiatry, 40(2), 317–328. https://doi.org/10 Iliakis, E. A., Sonley, A. K. I., Ilagan, G. S., & Choi-Kain, L. W. (2019).
.1016/j.jbtep.2009.01.002 Treatment of borderline personality disorder: Is supply adequate to meet
Feigenbaum, J. D., Fonagy, P., Pilling, S., Jones, A., Wildgoose, A., & public health needs? Psychiatric Services, 70(9), 772–781. https://doi.org/
Bebbington, P. E. (2012). A real-world study of the effectiveness of DBT 10.1176/appi.ps.201900073
in the UK National Health Service. British Journal of Clinical Psychology, Jørgensen, C. R., Freund, C., Bøye, R., Jordet, H., Andersen, D., & Kjølbye,
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
Lohr, K. N. (2012). Clinical heterogeneity in systematic reviews and Leppänen, V., Hakko, H., Sintonen, H., & Lindeman, S. (2016). Comparing
health technology assessments: Synthesis of guidance documents and the effectiveness of treatments for borderline personality disorder in communal
literature. International Journal of Technology Assessment in Health mental health care: The Oulu BPD study. Community Mental Health
Care, 28(1), 36–43. https://doi.org/10.1017/S0266462311000687 Journal, 52(2), 216–227. https://doi.org/10.1007/s10597-015-9866-4
Giesen-Bloo, J., van Dyck, R., Spinhoven, P., van Tilburg, W., Dirksen, C., Linehan, M. M. (1993). Cognitive-behavioral treatment of borderline
van Asselt, T., Kremers, I., Nadort, M., & Arntz, A. (2006). Outpatient personality disorder. Guilford Press.
psychotherapy for borderline personality disorder: Randomized trial of Links, P. S., Kolla, N. J., Guimond, T., & McMain, S. (2013). Prospective
schema-focused therapy vs transference-focused psychotherapy. Archives risk factors for suicide attempts in a treated sample of patients with
of General Psychiatry, 63(6), 649–658. https://doi.org/10.1001/archpsyc borderline personality disorder. Canadian Journal of Psychiatry, 58(2),
.63.6.649 99–106. https://doi.org/10.1177/070674371305800207
González-González, S., Marañón-González, R., Hoyuela-Zatón, F., Gómez- Lunny, C., Ramasubbu, C., Puil, L., Liu, T., Gerrish, S., Salzwedel, D. M.,
Carazo, N., Hernández-Abellán, A., Pérez-Poo, T., Umaran-Alfageme, O., Mintzes, B., & Wright, J. M. (2021). Over half of clinical practice
Cordero-Andrés, P., López-Sánchez, V., Black, D. W., Blum, N. S., Artal- guidelines use non-systematic methods to inform recommendations: A
Simón, J., & Ayesa-Arriola, R. (2021). STEPPS for borderline personality methods study. PLOS ONE, 16(4), Article e0250356. https://doi.org/10
disorder: A pragmatic trial and naturalistic comparison with noncompl- .1371/journal.pone.0250356
eters. Journal of Personality Disorders, 35(6), 841–856. https://doi.org/10 McMain, S. F., Guimond, T., Barnhart, R., Habinski, L., & Streiner, D. L.
.1521/pedi_2021_35_512 (2017). A randomized trial of brief dialectical behaviour therapy skills
Gregory, R. J., & Remen, A. L. (2008). A manual-based psychodynamic therapy training in suicidal patients suffering from borderline disorder. Acta
for treatment-resistant borderline personality disorder. Psychotherapy, Psychiatrica Scandinavica, 135(2), 138–148. https://doi.org/10.1111/
45(1), 15–27. https://doi.org/10.1037/0033-3204.45.1.15 acps.12664
Gregory, R. J., & Sachdeva, S. (2016). Naturalistic outcomes of evidence- McMain, S. F., Guimond, T., Streiner, D. L., Cardish, R. J., & Links, P. S.
based therapies for borderline personality disorder at a medical university (2012). Dialectical behavior therapy compared with general psychiatric
clinic. American Journal of Psychotherapy, 70(2), 167–184. https:// management for borderline personality disorder: Clinical outcomes and
doi.org/10.1176/appi.psychotherapy.2016.70.2.167 functioning over a 2-year follow-up. The American Journal of Psychiatry,
Guillén Botella, V., García-Palacios, A., Bolo Miñana, S., Baños, R., Botella, 169(6), 650–661. https://doi.org/10.1176/appi.ajp.2012.11091416
C., & Marco, J. H. (2021). Exploring the effectiveness of dialectical McMain, S. F., Links, P. S., Gnam, W. H., Guimond, T., Cardish, R. J.,
behavior therapy versus systems training for emotional predictability and Korman, L., & Streiner, D. L. (2009). A randomized trial of dialectical
problem solving in a sample of patients with borderline personality behavior therapy versus general psychiatric management for borderline
disorder. Journal of Personality Disorders, 35(Suppl. A), 21–38. https:// personality disorder. The American Journal of Psychiatry, 166(12), 1365–
doi.org/10.1521/pedi_2020_34_477 1374. https://doi.org/10.1176/appi.ajp.2009.09010039
Gunderson, J. G. (2009). Borderline personality disorder: Ontogeny of a Morton, J., Snowdon, S., Gopold, M., & Guymer, E. (2012). Acceptance
diagnosis. The American Journal of Psychiatry, 166(5), 530–539. https:// and commitment therapy group treatment for symptoms of borderline
doi.org/10.1176/appi.ajp.2009.08121825 personality disorder: A public sector pilot study. Cognitive and
Gunderson, J. G., Stout, R. L., McGlashan, T. H., Shea, M. T., Morey, L. C., Behavioral Practice, 19(4), 527–544. https://doi.org/10.1016/j.cbpra
Grilo, C. M., Zanarini, M. C., Yen, S., Markowitz, J. C., Sanislow, C., .2012.03.005
Ansell, E., Pinto, A., & Skodol, A. E. (2011). Ten-year course of National Collaborating Centre for Mental Health. (2018, August). Borderline
borderline personality disorder: Psychopathology and function from the personality disorder: The NICE guideline on treatment and management.
collaborative longitudinal personality disorders study. Archives of General The British Psychological Society and The Royal College of Psychiatrists.
Psychiatry, 68(8), 827–837. https://doi.org/10.1001/archgenpsychiatry https://www.nice.org.uk/guidance/cg78/evidence/bpd-full-guideline-
.2011.37 242147197
Hastrup, L. H., Jennum, P., Ibsen, R., Kjellberg, J., & Simonsen, E. (2019). Niesten, I. J., Karan, E., Frankenburg, F. R., Fitzmaurice, G. M., & Zanarini,
Societal costs of borderline personality disorders: A matched-controlled M. C. (2016). Description and prediction of the income status of borderline
nationwide study of patients and spouses. Acta Psychiatrica Scandinavica, patients over 10 years of prospective follow-up. Personality and Mental
140(5), 458–467. https://doi.org/10.1111/acps.13094 Health, 10(4), 285–292. https://doi.org/10.1002/pmh.1331
Hayes, S. C., Strosahl, K., & Wilson, K. G. (1999). Acceptance and Oldham, J. M. (2006). Borderline personality disorder and suicidality. The
commitment therapy: An experiential approach to behavior change. American Journal of Psychiatry, 163(1), 20–26. https://doi.org/10.1176/
Guilford Press. appi.ajp.163.1.20
Hilden, H. M., Rosenström, T., Karila, I., Elokorpi, A., Torpo, M., Arajärvi, Oud, M., Arntz, A., Hermens, M. L., Verhoef, R., & Kendall, T. (2018).
R., & Isometsä, E. (2021). Effectiveness of brief schema group therapy for Specialized psychotherapies for adults with borderline personality
PSYCHOTHERAPIES FOR BORDERLINE PERSONALITY DISORDER 21
disorder: A systematic review and meta-analysis. The Australian and New Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S.,
Zealand Journal of Psychiatry, 52(10), 949–961. https://doi.org/10.1177/ Boutron, I., Cates, C. J., Cheng, H. Y., Corbett, M. S., Eldridge, S. M.,
0004867418791257 Emberson, J. R., Hernán, M. A., Hopewell, S., Hróbjartsson, A.,
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Junqueira, D. R., Jüni, P., Kirkham, J. J., Lasserson, T., Li, T., … Higgins,
Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., J. P. T. (2019). RoB 2: A revised tool for assessing risk of bias in
Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., randomised trials. The BMJ, 366, Article l4898. https://doi.org/10.1136/
Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. bmj.l4898
(2021). The PRISMA 2020 statement: An updated guideline for reporting Storebø, O. J., Stoffers-Winterling, J. M., Völlm, B. A., Kongerslev, M. T.,
Content may be shared at no cost, but any requests to reuse this content in part or whole must go through the American Psychological Association.
systematic reviews. The BMJ, 372, Article n71. https://doi.org/10.1136/ Mattivi, J. T., Jørgensen, M. S., Faltinsen, E., Todorovac, A., Sales, C. P.,
bmj.n71 Callesen, H. E., Lieb, K., & Simonsen, E. (2020). Psychological
Paris, J. (2019). Suicidality in borderline personality disorder. Medicina, therapies for people with borderline personality disorder. Cochrane
55(6), Article 223. https://doi.org/10.3390/medicina55060223 Database of Systematic Reviews, 5, Article CD012955. https://doi.org/10
Sachdeva, S., Goldman, G., Mustata, G., Deranja, E., & Gregory, R. J. .1002/14651858.CD012955.pub2
(2013). Naturalistic outcomes of evidence-based therapies for borderline Torgersen, J. (2005). Textbook of personality disorders. American
personality disorder at a university clinic: A quasi-randomized trial. Psychiatric Association.
This document is copyrighted by the American Psychological Association or one of its allied publishers.
Journal of the American Psychoanalytic Association, 61(3), 578–584. van den Bosch, L. M., Koeter, M. W., Stijnen, T., Verheul, R., & van den
https://doi.org/10.1177/0003065113490637 Brink, W. (2005). Sustained efficacy of dialectical behaviour therapy for
Sharp, C., & Wall, K. (2018). Personality pathology grows up: Adolescence borderline personality disorder. Behaviour Research and Therapy, 43(9),
as a sensitive period. Current Opinion in Psychology, 21, 111–116. https:// 1231–1241. https://doi.org/10.1016/j.brat.2004.09.008
doi.org/10.1016/j.copsyc.2017.11.010 Verheul, R., Van Den Bosch, L. M., Koeter, M. W., De Ridder, M. A.,
Simonsen, S., Bateman, A., Bohus, M., Dalewijk, H. J., Doering, S., Kaera, A., Stijnen, T., & Van Den Brink, W. (2003). Dialectical behaviour therapy
Moran, P., Renneberg, B., Ribaudi, J. S., Taubner, S., Wilberg, T., & for women with borderline personality disorder: 12-month, randomised
Mehlum, L. (2019). European guidelines for personality disorders: Past, clinical trial in the Netherlands. The British Journal of Psychiatry, 182(2),
present and future. Borderline Personality Disorder and Emotion 135–140. https://doi.org/10.1192/bjp.182.2.135
Dysregulation, 6(1), Article 9. https://doi.org/10.1186/s40479-019-0106-3 Weinberg, I., Gunderson, J. G., Hennen, J., & Cutter, C. J., Jr. (2006).
Skodol, A. E., & Bender, D. S. (2003). Why are women diagnosed borderline Manual assisted cognitive treatment for deliberate self-harm in borderline
more than men? Psychiatric Quarterly, 74(4), 349–360. https://doi.org/10 personality disorder patients. Journal of Personality Disorders, 20(5),
.1023/A:1026087410516 482–492. https://doi.org/10.1521/pedi.2006.20.5.482
Spinhoven, P., Giesen-Bloo, J., van Dyck, R., Kooiman, K., & Arntz, A. Winsper, C., Bilgin, A., Thompson, A., Marwaha, S., Chanen, A. M., Singh,
(2007). The therapeutic alliance in schema-focused therapy and S. P., Wang, A., & Furtado, V. (2020). The prevalence of personality
transference-focused psychotherapy for borderline personality disorder. disorders in the community: A global systematic review and meta-
Journal of Consulting and Clinical Psychology, 75(1), 104–115. https:// analysis. The British Journal of Psychiatry, 216(2), 69–78. https://doi.org/
doi.org/10.1037/0022-006X.75.1.104 10.1192/bjp.2019.166
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D.,
Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I.,
Carpenter, J. R., Chan, A. W., Churchill, R., Deeks, J. J., Hróbjartsson, A.,
Kirkham, J., Jüni, P., Loke, Y. K., Pigott, T. D., … Higgins, J. P. (2016).
ROBINS-I: A tool for assessing risk of bias in non-randomised studies of Received January 13, 2023
interventions. The BMJ, 355, Article i4919. https://doi.org/10.1136/ Revision received April 26, 2023
bmj.i4919 Accepted June 12, 2023 ▪